Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Adult Chronic Severe ITP Candidates for Splenectomy
NCT00225875Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in immune thrombocytopenic purpura (ITP), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2003; status: terminated.
02
Drugs
rituximab
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00225875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225875.